Loteprednol Etabonate NDC 24208-508

NDC codes

FDA NDC Directory

Product NDC (as listed)24208-508Labeler and product segments. Claims need a package NDC.

Product NDC at billing width24208-0508Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
24208-508-01	24208050801	1 BOTTLE in 1 CARTON (24208-508-01) / 5 g in 1 BOTTLEMarketed from Feb 17, 2021

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Loteprednol Etabonate
Generic name (nonproprietary): loteprednol etabonate
Active ingredients: Loteprednol etabonate — 5 mg/g
Dosage form: Gel
Route: Ophthalmic
Labeler: Bausch & Lomb Incorporated
Product type: Prescription drug
Marketing category: NDA authorized genericApplication NDA 202872
Marketing start: Feb 17, 2021
Listing expires: Dec 31, 2026
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 24208-508_0cdbef52-3996-4d79-85ae-c5dd70ac93edSPL ID 0cdbef52-3996-4d79-85ae-c5dd70ac93edSPL set ID 7bbdbd31-5a8f-4d69-aa8e-5b700895e804RxCUI 1312625UNII YEH1EZ96K6
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N424208050801 followed by a unit qualifier and the quantity

Package 24208-0508-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 31, 2021.

Indications (excerpt from the label)

Loteprednol Etabonate Ophthalmic Gel is a corticosteroid indicated for the treatment of post-operative inflammation and pain following ocular surgery. Loteprednol Etabonate Ophthalmic Gel is a corticosteroid indicated for the treatment of postoperative inflammation and pain following ocular surgery. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 202872

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 202872
Product	Strength	Form · route	Labeler	Product NDC
Lotemaxloteprednol etabonate	Loteprednol etabonate 5 mg/g	GelOphthalmic	Bausch & Lomb Incorporated	24208-503
Loteprednol Etabonate	Loteprednol etabonate 5 mg/g	GelOphthalmic	Bausch & Lomb Americas Inc.	82260-508